ACTIVE

Pharmadil

Export PDF

Financial year 2024 · closed on 31/03/2024

Net result

-69,1 k €

-60.0% YoY

Gross margin

159,6 k €

-12.1% YoY

Equity

-88 k €

-365.4% YoY

Workforce

2,0 ETP

0.0% YoY

What does Pharmadil do?

Pharmadil is a Private limited company incorporated in 2014. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Dilbeek. It employs on average 2,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0549.774.521

Incorporation

28/03/2014

Legal form

Private limited company

Registered office

Baron R. de Vironlaan 162
1700 Dilbeek · FlandreSee on map

Contributed capital

25 000,00 €

Latest accounts

31/03/2024

Average workforce

2,0 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores

Joint committees (1)

Signals

Positive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 10 financial years

	2024		2023		2022		2021		2020		2019		2018		2017		2016		2015
Income statement
Gross margin	159,6 k €	-12.1%	181,7 k €	-14.3%	212 k €	+25.1%	169,5 k €	-21.9%	217 k €	-18.3%	265,7 k €	-1.5%	269,7 k €	-16.4%	322,8 k €	-2.5%	331,1 k €	+9.9%	301,4 k €
EBITDA	22,2 k €	-53.8%	48 k €	-52.3%	100,7 k €	+46.6%	68,7 k €	-32.8%	102,1 k €	-24.0%	134,3 k €	+12.6%	119,3 k €	-34.9%	183,2 k €	-6.1%	195,1 k €	+27.6%	152,9 k €
Operating result	-58,2 k €	-74.3%	-33,4 k €	-287%	17,9 k €	+229%	-13,9 k €	-167%	20,6 k €	-34.7%	31,5 k €	+113%	14,8 k €	-81.2%	78,8 k €	-13.6%	91,2 k €	+76.0%	51,8 k €
Net result	-69,1 k €	-60.0%	-43,2 k €	-1149%	4,1 k €	+114%	-28,5 k €	-762%	4,3 k €	-54.7%	9,5 k €	+409%	-3,1 k €	-105%	56,2 k €	-14.3%	65,6 k €	+296%	16,6 k €
Balance sheet
Equity	-88 k €	-365%	-18,9 k €	-178%	24,3 k €	+20.4%	20,2 k €	-58.6%	48,6 k €	+0.6%	48,3 k €	+24.5%	38,8 k €	-7.3%	41,9 k €	+0.5%	41,7 k €	+0.3%	41,6 k €
Total assets	620,7 k €	-15.0%	730,2 k €	-8.8%	800,6 k €	-2.0%	817 k €	-5.4%	863,3 k €	-3.9%	898 k €	-7.2%	967,5 k €	-7.8%	1 M €	-10.2%	1,2 M €	-2.6%	1,2 M €
Cash	63,6 k €	+211%	20,5 k €	-15.3%	24,2 k €	+16.4%	20,8 k €	-52.6%	43,8 k €	+8.2%	40,5 k €	-25.1%	54,1 k €	+0.6%	53,8 k €	-31.4%	78,4 k €	+6.1%	73,9 k €
Debts	705,5 k €	-5.4%	746 k €	-3.6%	773,6 k €	-2.6%	794,2 k €	-2.2%	812,1 k €	-4.1%	847,1 k €	-8.5%	926,3 k €	-7.8%	1 M €	-10.6%	1,1 M €	-2.7%	1,2 M €
Other
Workforce	2,0 ETP	0.0%	2,0 ETP	0.0%	2,0 ETP	+25.0%	1,6 ETP	-11.1%	1,8 ETP	+5.9%	1,7 ETP	-15.0%	2,0 ETP	+5.3%	1,9 ETP	+5.6%	1,8 ETP	0.0%	1,8 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/03/2024 · 1 active · 6 ended

Active mandates

MSP INVEST

Director · since 01 avril 2019 · 0847.972.515

Represented by Philippe Germonpré

Active

Ended mandates

MSP INVEST

Director · since 01 avril 2019 · 0847.972.515

Represented by Philippe Germonpré

Ended

MSP INVEST

Manager · since 01 avril 2019 · 0847.972.515

Represented by Philippe Germonpré

Ended

MSP INVEST

Manager · since 01 avril 2019 · 0847.972.515

Represented by Philippe Germonpré

Ended

APODIL

Manager · 0465.888.129

Represented by Philippe Germonpre

Ended

At this address

Other companies at this address

Company	CBE no.
AML EXPRESS● Active	0783.638.947

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/04/2023	01/04/2022	01/04/2021	01/04/2020	01/04/2019	01/04/2018
Closing of the financial year	31/03/2024	31/03/2023	31/03/2022	31/03/2021	31/03/2020	31/03/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	13/11/2024	30/10/2023	10/11/2022	16/11/2021	26/11/2020	10/10/2019
General meeting	30/08/2024	25/08/2023	26/08/2022	17/09/2021	18/09/2020	30/08/2019
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

10 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/03/2024	30/08/2024	13/11/2024	Dutch	PDF
Abridged model	31/03/2023	25/08/2023	30/10/2023	Dutch	PDF
Abridged model	31/03/2022	26/08/2022	10/11/2022	Dutch	PDF
Abridged model	31/03/2021	17/09/2021	16/11/2021	Dutch	PDF
Abridged model	31/03/2020	18/09/2020	26/11/2020	Dutch	PDF
Abridged model	31/03/2019	30/08/2019	10/10/2019	Dutch	PDF
Abridged model	31/03/2018	31/08/2018	23/10/2018	Dutch	PDF
Abridged model	31/03/2017	25/08/2017	15/09/2017	Dutch	PDF
Abridged model	31/03/2016	26/08/2016	06/09/2016	Dutch	PDF
Abridged model	31/03/2015	28/08/2015	06/10/2015	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2024 · 1 active · 6 ended

Active mandates

MSP INVEST

Director · since 01 avril 2019 · 0847.972.515

Represented by Philippe Germonpré

Active

Ended mandates

MSP INVEST

Director · since 01 avril 2019 · 0847.972.515

Represented by Philippe Germonpré

Ended

MSP INVEST

Manager · since 01 avril 2019 · 0847.972.515

Represented by Philippe Germonpré

Ended

MSP INVEST

Manager · since 01 avril 2019 · 0847.972.515

Represented by Philippe Germonpré

Ended

APODIL

Manager · 0465.888.129

Represented by Philippe Germonpre

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Registered office25/02/2025
MAATSCHAPPELIJKE ZETEL
PDF
Mandates24/05/2023
WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates12/04/2019
ONTSLAGEN - BENOEMINGEN
PDF
Other01/04/2014
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 2024-69,1 k €↓
2023
Annual accounts 2023-43,2 k €↓
2022
Annual accounts 20224,1 k €↑
2021
Annual accounts 2021-28,5 k €↓
2020
Annual accounts 20204,3 k €↓
2019
Annual accounts 20199,5 k €↑
2018
Annual accounts 2018-3,1 k €↓
2017
Annual accounts 201756,2 k €↓
2016
Annual accounts 201665,6 k €↑
2015
Annual accounts 201516,6 k €
28/03/2014
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Pharmadil

Overview

What does Pharmadil do?

Trend over 10 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline